99-20380. Agency Forms Undergoing Paperwork Reduction Act Review  

  • [Federal Register Volume 64, Number 152 (Monday, August 9, 1999)]
    [Notices]
    [Page 43188]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-20380]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    [30DAY-16-99]
    
    
    Agency Forms Undergoing Paperwork Reduction Act Review
    
        The Centers for Disease Control and Prevention (CDC) publishes a 
    list of information collection requests under review by the Office of 
    Management and Budget (OMB) in compliance with the Paperwork Reduction 
    Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
    the CDC Reports Clearance Officer at (404) 639-7090. Send written 
    comments to CDC, Desk Officer; Human Resources and Housing Branch, New 
    Executive Office Building, Room 10235; Washington, DC 20503. Written 
    comments should be received within 30 days of this notice.
    
    Proposed Project
    
        1. National Surveillance of Dialysis-Associated Diseases (0920-
    0009)--Reinstatement--National Center for Infectious Diseases (NCID). 
    The Hospital Infectious Program, NCID is proposing renewal of a yearly 
    mail survey of dialysis practices and dialysis-associated diseases at 
    U.S. outpatient hemodialysis centers. The rehabilitation of individuals 
    in the United States who suffer from chronic renal failure has been 
    identified as an important national priority; and since 1973, chronic 
    hemodialysis patients have been provided financial support by the 
    Federal Government. The Hospital Infections Program and the Hepatitis 
    Branch, Division of Viral and Rickettsial Diseases, Centers for Disease 
    Control and Prevention, have responsibility for formulating strategies 
    for the control of hepatitis, bacteremia, pyrogenic reactions, and 
    other hemodialysis-associated disease.
        In order to devise such control measures, it is necessary to 
    determine the extent to which the incidence of these dialysis-
    associated diseases changes over time. This request is to continue 
    surveillance activities among chronic hemodialysis centers nationwide. 
    In addition, once control measures are recommended it is essential that 
    such measures be monitored to determine their effectiveness. The survey 
    is conducted once a year by mailing it to all chronic hemodialysis 
    centers licensed by the Health Care Financing Administration (HCFA). 
    Dialysis practices surveyed include the use of hepatitis B vaccine in 
    patients and staff members, whether isolation rooms are used to treat 
    hepatitis B surface antigen-positive patients, the types of vascular 
    access and dialyzers used, whether certain dialysis items are 
    disinfected for reuse, and whether the dialysis center has any policy 
    for insuring judicious use of antimicrobial agents. Among dialysis-
    associated diseases, the survey includes hepatitis B virus infection, 
    antibody to hepatitis C virus, antibody to human immunodeficiency 
    virus, pyrogenic reactions, and vancomycin-resistant enterococci. The 
    total annual burden hours are 3200.
    
    ----------------------------------------------------------------------------------------------------------------
                                                                                       Number of       Avg. Burden/
                             Respondents                              Number of        responses/     response  (in
                                                                     respondents       respondent         hrs.)
    ----------------------------------------------------------------------------------------------------------------
    Chronic Hemodialysis Centers.................................           3,200                1                1
    ----------------------------------------------------------------------------------------------------------------
    
        Dated: August 3, 1999.
    Nancy Cheal,
    Acting Associate Director for Policy, Planning and Evaluation, Centers 
    for Disease Control and Prevention (CDC).
    [FR Doc. 99-20380 Filed 8-6-99; 8:45 am]
    BILLING CODE 4163-18-P
    
    
    

Document Information

Published:
08/09/1999
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
99-20380
Pages:
43188-43188 (1 pages)
Docket Numbers:
30DAY-16-99
PDF File:
99-20380.pdf